All In MedTech

Device Trial Radar · NCT02675751

Prospective S&E Study of Wavefront-guided PRK for Myopia With iDesign Advanced Wavescan Studio™ System and Star S4 IR™

A Prospective Study to Evaluate the Safety and Effectiveness of Wavefront-guided PRK Correction of Myopic Refractive Errors With the iDesign Advanced Wavescan Studio™ System and the Star S4 IR™ Excimer Laser System

Last checked: Nov 20, 2026Latest source record: Feb 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

167

Actual

Start

Feb 3, 2016

Primary completion

Jul 27, 2018

Study completion Jul 27, 2018

Sponsor

Lead sponsor
Abbott Medical OpticsPublic (ABT)
Sponsor type
Industry
First posted
Feb 5, 2016

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Prospective, multicenter, bilaterally-treated, open-label, non-randomized clinical trial.

Conditions

  • Stable Myopic Refractive Error, With or Without Astigmatism

Interventions

  • STAR S4 IR laser with iDesignDevice

    Surgeons will perform wavefront-guided PRK for the treatment of myopic refractive errors based upon measurements obtained with the iDesign System using the STAR S4 IR laser.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The Percentage of Eyes Achieving the Target of Monocular Uncorrected Visual Acuity of 20/40 or BetterTime frame: 6 months

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.